Abbott Laboratories DEF 14A proxy statements

Abbott Laboratories announces its 2026 Annual Meeting of Shareholders, detailing director elections, executive compensation, and equity plan approvals, while reporting strong 2025 total shareholder return.

Abbott Laboratories announces its annual shareholder meeting to be held virtually on April 25, 2025, with key items including the election of directors, ratification of auditors, and an advisory vote on executive compensation.

Abbott Laboratories' 2025 proxy statement details the election of directors, executive compensation, corporate governance, and sustainability initiatives, highlighting strong shareholder returns and a commitment to long-term growth.

Abbott Laboratories will hold its annual shareholder meeting virtually on April 26, 2024, to vote on the election of directors, ratification of auditors, and executive compensation.

Abbott Laboratories' 2024 proxy statement details the company's executive compensation program, corporate governance practices, and shareholder engagement efforts, highlighting a commitment to aligning executive pay with company performance and shareholder returns.